Cargando…
MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
Malignant pleural mesothelioma (MPM) is an incurable cancer of the pleura that can be difficult to diagnose. Biomarkers for an easier and/or earlier diagnosis are needed. Approximately 90% of MPM patients develop a pleural effusion (PE). PEs are ideal sources of biomarkers as the fluid would almost...
Autores principales: | Birnie, Kimberly A., Prêle, Cecilia M., Musk, Arthur W. (Bill), de Klerk, Nicholas, Lee, Y. C. Gary, Fitzgerald, Deirdre, Allcock, Richard J. N., Thompson, Philip J., Creaney, Jenette, Badrian, Bahareh, Mutsaers, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701424/ https://www.ncbi.nlm.nih.gov/pubmed/31481984 http://dx.doi.org/10.1155/2019/8628612 |
Ejemplares similares
-
Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020) -
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
por: Birnie, Kimberly A., et al.
Publicado: (2017) -
Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014) -
Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
por: Creaney, Jenette, et al.
Publicado: (2013) -
Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis
por: Lim, Chuan Bian, et al.
Publicado: (2015)